Evidence map›Paper›PMID 38743493›Full record

ArticleProtein & cell2024

Syn3, a newly developed cyclic peptide and BDNF signaling enhancer, ameliorates retinal ganglion cell degeneration in diabetic retinopathy.

Ke-Ran Li, Meng-Jia Huan, Jin Yao, Jia-Jun Li, Yuan Cao, Suyu Wang, Mandar T Naik, Yuan Fang, John Marshall, Chang-Gong Lan and 1 more

Abstract read
In one paragraph

Article in Protein & cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Peptidomimetic inhibitors targeting TrkB/PSD-95 signaling improves cognition and seizure outcomes in an Angelman Syndrome mouse model.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ke-Ran LiThe Affiliated Eye Hospital, Nanjing Medical University, Nanjing 210029, China.ORCID 0000-0003-1134-3490
Meng-Jia HuanDepartment of Ophthalmology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.ORCID 0009-0003-0145-5082
Jin YaoThe Affiliated Eye Hospital, Nanjing Medical University, Nanjing 210029, China.ORCID 0000-0003-0197-3296
Jia-Jun LiThe Affiliated Eye Hospital, Nanjing Medical University, Nanjing 210029, China.ORCID 0009-0002-2329-3013
Yuan CaoThe Affiliated Eye Hospital, Nanjing Medical University, Nanjing 210029, China.ORCID 0000-0002-5873-2293
Suyu WangThe Affiliated Eye Hospital, Nanjing Medical University, Nanjing 210029, China.ORCID 0009-0006-6369-892X
Mandar T NaikDepartment of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI 02912,United States.ORCID 0000-0002-7016-572X
Yuan FangDepartment of Ophthalmology & Vision Science, Eye and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai 200433, China.ORCID 0000-0001-6272-6569
John MarshallDepartment of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI 02912,United States.ORCID 0000-0002-9937-0268
Chang-Gong LanDepartment of Joint Surgery and Geriatric Orthopedics, Affiliated Hospital of YouJiang Medical University for Nationalities, Guangxi Key Laboratory of Basic and Translational Research of Bone and Joint Degenerative Diseases, Guangxi Biomedical Materials Engineering Research Center for Bone and Joint Degenerative Diseases, Baise 533000, China.ORCID 0000-0002-9937-0268
Cong CaoClinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Institution of Neuroscience, Soochow University, Suzhou 215031, China.ORCID 0000-0003-0824-3472

Funding

National Natural Science Foundation of China 81922025
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38743493
PMCPMC11528515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.